A photography exhibition showcasing ground-breaking NHS research taking place across the Thames Valley can now be viewed by visitors and staff at Oxford’s John Radcliffe Hospital. ‘The Body Unlocked: How Research is Changing Lives’ features life-sized photographs of people who have taken part in studies, researchers at work and microscopic images of cells and bacteria. … Read more
Minimal risk of catching COVID-19 as a result of endoscopy, study finds
More than 6,000 patients who underwent endoscopy at 18 NHS hospitals since the start of pandemic have been tested and none contracted COVID as a result of the procedure, a study involving clinicians from Oxford University Hospitals (OUH) NHS Foundation Trust has found. Clinicians hope the findings will persuade people that it is safe to … Read more
Oxford study reveals medium-term impact of COVID-19
Initial findings from a study looking at the longer-term impact of COVID-19 has found that a large proportion COVID-19 patients discharged from hospital were still experiencing symptoms of breathlessness, fatigue, anxiety and depression two to three months after contracting the virus. The University of Oxford scientists carrying out the C-MORE study have also detected abnormalities … Read more
Researchers develop tool to monitor gender equity in Biomedical Research Centres
Researchers from the NIHR Oxford Biomedical Research Centre (BRC) have developed a tool to rank and identify new gender equity markers specific to NIHR BRCs. In an article published in the PLOS ONE journal, the BRC researchers identified two distinct dimensions to monitoring gender equity: ‘organisational markers’ and ‘individual markers’. The findings were based on … Read more
Challenges around recruitment and retention in surgical trials highlighted
A study by Oxford BRC-supported researchers has identified the main challenges associated with the recruitment and retention of participants in surgical trials in the UK. The study was part of the PIRRIST project, which aims to enhance recruitment and retention in surgical trials by involving patients and the public in developing the trials. It was published … Read more
Prof Sarah Walker receives OBE
Professor Sarah Walker, the Oxford BRC’s Co-theme Lead for Antimicrobial Resistance and Modernising Microbiology, is to receive an OBE. Prof Walker, Professor of Medical Statistics and Epidemiology at the University of Oxford’s Nuffield Department of Medicine, was recognised for services to academia and the COVID-19 response. She is the chief investigator and academic lead for … Read more
Hydroxychloroquine does not benefit hospitalised COVID-19 patients, RECOVERY Trial finds
Oxford scientists have confirmed that there is no clinical benefit from using hydroxychloroquine on COVID-19 patients in hospital. The findings were published in the New England Journal of Medicine. Hydroxychloroquine was one of the potential COVID-19 treatments being studied as part of the RECOVERY Trial, the world’s biggest trial looking at whether existing treatments can tackle … Read more
Hospitalised COVID-19 patients ‘younger and healthier than flu patients’
Patients hospitalised with COVID-19 were more likely male, younger and – in the US and Spain – had fewer comorbidities and lower medication use than hospitalized influenza patients according to a study published by the Observational Health Data Sciences and Informatics (OHDSI) community. This global network study, which included more than 34,000 COVID-19 patients from … Read more
Patients with cirrhosis at increased risk of death from COVID-19, study finds
An international study led by researchers at Oxford University Hospitals NHS Foundation Trust has shown that patients with cirrhosis are at increased risk of dying as a result of COVID-19. The study, published in the Journal of Hepatology, found that mortality from COVID-19 was particularly high among patients with more advanced cirrhosis (called Childs-Pugh B … Read more
New trial on use of anti-TNF drugs to treat Covid-19 in care homes
Researchers at the University of Oxford are starting a new study to explore the effectiveness of a common arthritis drug, adalimumab, as a treatment for patients with COVID-19 in the community, especially care homes. Recent studies of patients with COVID-19 have shown that patients already taking anti-tumour necrosis factor drugs for inflammatory arthritis and inflammatory … Read more
- 1
- 2
- 3
- …
- 55
- Next Page »